UnitedHealth Group (NYSE:UNH) Stock Price Target Raised at Morgan Stanley

UnitedHealth Group (NYSE:UNH) had its target price increased by analysts at Morgan Stanley from $529.00 to $531.00 in a research report issued on Tuesday, Benzinga reports. The brokerage presently has an “overweight” rating on the healthcare conglomerate’s stock. Morgan Stanley‘s target price suggests a potential upside of 29.26% from the company’s previous close.

A number of other research analysts also recently weighed in on the company. Erste Group Bank downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, August 27th. The Goldman Sachs Group lifted their price target on UnitedHealth Group from $435.00 to $490.00 and gave the company a “buy” rating in a research report on Friday, July 17th. HSBC upped their price target on UnitedHealth Group from $300.00 to $380.00 and gave the stock a “hold” rating in a research note on Monday, July 6th. Barclays decreased their price objective on UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating for the company in a report on Wednesday, October 14th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on UnitedHealth Group from $370.00 to $467.00 and gave the company a “hold” rating in a research report on Friday, July 17th. Twenty research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average price target of $463.93.

UnitedHealth Group Stock Down 1.7%

Shares of NYSE UNH opened at $410.81 on Tuesday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78. UnitedHealth Group has a one year low of $255.96 and a one year high of $461.62. The stock has a market capitalization of $368.74 billion, a PE ratio of 23.46, a P/E/G ratio of 1.51 and a beta of 0.60. The business’s fifty day moving average price is $388.57 and its 200-day moving average price is $360.79.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The firm had revenue of $112.70 billion for the quarter, compared to analyst estimates of $111.31 billion. During the same quarter in the prior year, the firm earned $2.59 EPS. The business’s revenue for the quarter was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities research analysts anticipate that UnitedHealth Group will post 20.62 EPS for the current year.

Insider Activity

In other news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.19% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in UNH. Midland Wealth Advisors LLC increased its stake in UnitedHealth Group by 2.8% during the 3rd quarter. Midland Wealth Advisors LLC now owns 1,063 shares of the healthcare conglomerate’s stock valued at $390,000 after purchasing an additional 29 shares in the last quarter. Total Clarity Wealth Management Inc. lifted its stake in shares of UnitedHealth Group by 20.0% in the third quarter. Total Clarity Wealth Management Inc. now owns 1,574 shares of the healthcare conglomerate’s stock worth $578,000 after buying an additional 262 shares in the last quarter. Lodestar Private Asset Management LLC purchased a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $521,000. Penobscot Investment Management Company Inc. grew its holdings in shares of UnitedHealth Group by 9.8% during the third quarter. Penobscot Investment Management Company Inc. now owns 23,601 shares of the healthcare conglomerate’s stock valued at $8,663,000 after buying an additional 2,098 shares during the last quarter. Finally, Cahaba Wealth Management Inc. increased its position in shares of UnitedHealth Group by 4.5% during the third quarter. Cahaba Wealth Management Inc. now owns 1,393 shares of the healthcare conglomerate’s stock valued at $511,000 after acquiring an additional 60 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.